Demographics, Adherence, and Satisfaction of Home UV Phototherapy in Psoriasis

Main Article Content

A Pona
Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina

A Cline
Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina

SS Kolli
Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina

SR Feldman
Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina

Keywords

Psoriasis, UV Phototherapy

Abstract

Abstract not available.

References

1. Rajpara AN1, O'Neill JL, Nolan BV, Yentzer BA, Feldman SR. Review of home phototherapy.
Dermatol Online J. 2010 Dec 15;16(12):2.
2. Koek MB, Buskens E, van Weelden H, Steegmans PH, Bruijnzeel-Koomen CA, Sigurdsson V. Home
versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre
randomised controlled non-inferiority trial (PLUTO study). BMJ. 2009 May.338:b1542. [PubMed:
19423623]
3. Koek MB, Sigurdsson V, van WH, et al. Cost effectiveness of home ultraviolet B phototherapy for
psoriasis: economic evaluation of a randomised controlled trial (PLUTO study). BMJ
2010;340:c1490

Article Sidebar

Poster PDF
Published
Jan 28, 2020

Article Details

How to Cite
[1]
Pona, A., Cline, A., Kolli, S. and Feldman, S. 2020. Demographics, Adherence, and Satisfaction of Home UV Phototherapy in Psoriasis. SKIN The Journal of Cutaneous Medicine. 4, 1 (Jan. 2020), S6.
Issue
Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
Section
Poster Presentations at 2020 Winter Clinical Dermatology Conference®: Psoriasis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.